Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cholangiocyte plasma membrane refers to the polarized cell surface of cholangiocytes, the epithelial cells lining intrahepatic and extrahepatic bile ducts, divided into apical (luminal) and basolateral domains separated by tight junctions that maintain epithelial polarity. This membrane hosts critical transporters and channels enabling cholangiocytes' primary role in modifying primary hepatocyte-derived bile through vectorial secretion of bicarbonate-rich fluid and reabsorption of solutes like bile acids, glucose, and amino acids. Key apical components include CFTR (cAMP-regulated Cl⁻ channel), AE2 (Cl⁻/HCO₃⁻ exchanger), AQP1 (water channel), ASBT (Na⁺-dependent bile acid transporter), and PMCA (Ca²⁺ pump), while basolateral elements feature AQP4, Ostα-Ostβ (bile acid exporters), GLUT1 (glucose transporter), and receptors like secretin receptor driving cAMP signaling for secretion. Heterogeneity exists between small (proliferative, Ca²⁺-sensitive) and large (secretory, cAMP-responsive) cholangiocytes, influencing membrane protein expression and function. Dysfunctions in these membrane mechanisms contribute to diseases like cholangiocarcinoma and cholestasis, but the membrane itself is not a discrete therapeutic target; instead, specific embedded proteins (e.g., CFTR) are pursued.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cholangiocyte plasma membrane.